IL17A and COVID-19: We also measured IL-17 levels in post-COVID-19 patients since it is well known that this cytokine is persistently altered in several chronic inflammatory and autoimmune diseases62, and previous reports have indicated an increased risk of such diseases in COVID-19 patients15.